What AI says about Exact Sciences

Data as of Oct 21, 2026Based on 2,677 AI responsesReviewed by

How we measure

exactsciences.com

AI summary

Exact Sciences develops cancer screening and genomic testing solutions including Cologuard, Cancerguard, and genomic assays such as Oncotype DX to assist in the detection, diagnosis, and treatment management of cancer.

Mentioned in

1%

across Exact Sciences’s markets · since Jul 5

Exact Sciences in AI’s own words

Question: What's the best multi-cancer early-detection blood test available now?

Google AI ModeSep 21, 2026

Exact Sciences' Cancerguard is another prominent laboratory-developed option.

Ask Google AI Mode yourself (opens in a new tab)

Question: Which startups help doctors use patient-specific diagnostics to choose treatments earlier?

ChatGPT SearchAug 8, 2026

companies such as Exact Sciences have launched comprehensive genomic tests specifically for therapy selection

Ask ChatGPT yourself (opens in a new tab)

Question: What's the best multi-cancer early-detection blood test available now?

Google AI ModeSep 1, 2026

the Cancerguard test by Exact Sciences are the leading multi-cancer early-detection (MCED) blood tests available today

Ask Google AI Mode yourself (opens in a new tab)

Where AI mentions Exact Sciences

Position in answers

  • Named first0%
  • 2nd or 3rd84%
  • Later16%

Each engine’s share of its own answers across Exact Sciences’s markets · since Jul 5

  • ChatGPT Search1%
  • Google AI Mode1%

The page AI cites most for Exact Sciences

exactsciences.com faviconexactsciences.com/cancer-testing/cancerguard-mced-providersCancerguard® Multi-Cancer Early Detection Test (opens in a new tab)23%of answers

Questions and answers

Sources AI cites

exactsciences.com 56%Other sites 44%